The company may face “short-term disruption from continued and new restrictions and lockdowns as communities continue to struggle to contain the spread of the virus while vaccination programs take place,” Chief Executive Officer
The CEO spoke after the pharmacy giant reported earnings that beat analysts’ expectations and reaffirmed it guidance for the 2021 fiscal year. Gains from its involvement in administering Covid-19 vaccines in the U.S. ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.